Published in Eur J Clin Microbiol Infect Dis on August 01, 1991
Enterobactin: an archetype for microbial iron transport. Proc Natl Acad Sci U S A (2003) 3.94
Anemia of chronic disease: a harmful disorder or an adaptive, beneficial response? CMAJ (2008) 1.12
Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi. Infect Immun (1994) 1.07
Salmonella typhi iron uptake mutants are attenuated in mice. Infect Immun (1994) 0.97
Iron and infection in hemodialysis patients. Semin Dial (2013) 0.88
Immunostimulation in the era of the metagenome. Cell Mol Immunol (2011) 0.79
Interactions between Hepatitis C Virus and the Human Apolipoprotein H Acute Phase Protein: A Tool for a Sensitive Detection of the Virus. PLoS One (2015) 0.75
Role of iron in bacterial infection. Curr Top Microbiol Immunol (1978) 5.92
Bacterial growth and the cell envelope. Bacteriol Rev (1970) 5.49
Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J (1972) 5.14
Autolytic enzyme-deficient mutants of Bacillus subtilis 168. J Bacteriol (1976) 4.17
Autolytic enzymes in growth of bacteria. Nature (1971) 3.63
Role of autolysins in the killing of bacteria by some bactericidal antibiotics. J Bacteriol (1971) 3.24
Cell wall or membrane mutants of Bacillus subtilis and Bacillus licheniformis with grossly deformed morphology. Nature (1968) 3.18
The abolition of the protective effect of Clostridium welchii type A antiserum by ferric iron. Immunology (1967) 2.89
Bacterial iron metabolism and immunity to Pasteurella septica and Escherichia coli. Nature (1969) 2.87
The effect of iron compounds on the virulence of Escherichia coli for guinea-pigs. Immunology (1968) 2.83
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia (2011) 2.82
Virulence and the role of iron in Pseudomonas aeruginosa infection. Infect Immun (1974) 2.69
Some enzymic activities and chemical properties of the mesosomes and cytoplasmic membranes of Bacillus licheniformis 6346. Biochem J (1969) 2.56
The abolition of the protective effect of Pasteurella septica antiserum by iron compounds. Immunology (1968) 2.50
The isolation and characterization of mutants of Bacillus subtilis and Bacillus licheniformis with disturbed morphology and cell division. J Gen Microbiol (1970) 2.27
Isolation and characterization of cell wall-defective variants of Bacillus subtilis and Bacillus licheniformis. J Bacteriol (1973) 2.09
Bacteriostatic effects of horse sera and serum fractions on Clostridium welchii Type A, and the abolition of bacteriostasis by iron salts. Immunology (1967) 2.08
The bacteriostatic effect of serum on Pasteurella septica and its abolition by iron compounds. Immunology (1971) 2.06
Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet (1982) 2.05
Effect of phosphate limitation on the morphology and wall composition of Bacillus licheniformis and its phosphoglucomutase-deficient mutants. J Bacteriol (1973) 1.96
Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique. Br J Clin Pharmacol (1977) 1.82
Rapid DNA extraction from ferns for PCR-based analyses. Biotechniques (1999) 1.81
Organization of polymers in the cell walls of some bacilli. Nature (1968) 1.79
Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) (1983) 1.79
The inhibition of mucopeptide synthesis by benzylpenicillin in relation to irreversible fixation of the antibiotic by staphylococci. Biochem J (1967) 1.79
Mapping of rod mutants of Bacillus subtilis. J Bacteriol (1972) 1.79
Hemochromatosis, iron and septicemia caused by Vibrio vulnificus. Arch Intern Med (1991) 1.65
Ferric iron and the antibacterial effects of horse 7S antibodies to Escherichia coli O111. Immunology (1976) 1.60
Is repeated flushing of Hickman catheters necessary? Br Med J (Clin Res Ed) (1985) 1.57
Iron compounds and resistance to infection. Further experiments with Clostridium welchii type A in vivo and in vitro. Immunology (1970) 1.53
Characterization of Bacillus licheniformis 6346 mutants which have altered lytic enzyme activities. J Bacteriol (1974) 1.45
Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br J Clin Pharmacol (1980) 1.45
Biogenesis of the wall in bacterial morphogenesis. Adv Microb Physiol (1979) 1.40
Modification of the appearance of mesosomes in sections of Bacillus licheniformis according to the fixation procedures. J Ultrastruct Res (1970) 1.40
High-voltage electrical injuries: management and outcome of 60 cases. South Med J (1988) 1.39
The occurrence of acquired immunodeficiency syndrome and unsuspected human immunodeficiency virus in burn patients. J Burn Care Rehabil (1989) 1.38
Purification and properties of autolytic endo-beta-N-acetylglucosaminidase and the N-acetylmuramyl-L-alanine amidase from Bacillus subtilis strain 168. J Gen Microbiol (1984) 1.37
Three-dimensional molecular models of bacterial cell wall mucopeptides (peptidoglycans). Proc Natl Acad Sci U S A (1971) 1.36
Comparative effectiveness of professional and paraprofessional helpers. Psychol Bull (1984) 1.35
Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci (1986) 1.31
Characterization of a tobacco gene encoding a pollen-specific polygalacturonase. Plant Mol Biol (1994) 1.29
Mucopeptide synthesis by rod mutants of Bacillus subtilis. J Gen Microbiol (1974) 1.28
Magnesium and anion requirements of rodB mutants of Bacillus subtilis. J Bacteriol (1976) 1.26
Bacteriostatic effect of human milk on Escherichia coli: the role of IgA. Immunology (1978) 1.22
Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography. Cancer Chemother Pharmacol (1978) 1.22
Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method. Eur J Clin Pharmacol (1980) 1.22
Iron binding proteins and infection. Br J Haematol (1972) 1.21
The chemistry of the cell walls of rod mutants of Bacillus subtilis. J Gen Microbiol (1971) 1.21
The role of L-glutamine in the phenotypic change of a rod mutant derived from Bacillus subtilis 168. J Gen Microbiol (1970) 1.20
Iron-binding catechols and virulence in Escherichia coli. Infect Immun (1973) 1.17
Abolition of passive immunity to bacterial infections by iron. Nature (1967) 1.15
Formation of cell wall polymers by reverting protoplasts of Bacillus licheniformis. J Bacteriol (1975) 1.15
Effect of cimetidine on the absorption of orally administered tetracycline. Br J Clin Pharmacol (1980) 1.14
Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol (1980) 1.13
An evaluation of 18S rDNA approaches for the study of fungal diversity in grassland soils. Microb Ecol (2004) 1.13
Comparative transport activity of intact cells, membrane vesicles, and mesosomes of Bacillus licheniformis. J Bacteriol (1973) 1.12
Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br J Clin Pharmacol (1979) 1.11
Ultrastructural study of the reversion of protoplasts of Bacillus licheniformis to bacilli. J Bacteriol (1975) 1.10
Peptidoglycans (mucopeptides): structure, function, and variations. Ann N Y Acad Sci (1974) 1.09
The structure and development of mesosomes studied in Bacillus licheniformis strain 6346. J Ultrastruct Res (1972) 1.09
Diversity, genetic structure and evidence of outcrossing in British populations of the rock fern Adiantum capillus-veneris using microsatellites. Mol Ecol (2001) 1.07
Partial characterization of the Nicotiana tabacum actin gene family: evidence for pollen-specific expression of one of the gene family members. Mol Gen Genet (1993) 1.07
A rapid method for determination of acetylation phenotype using dapsone. Br J Clin Pharmacol (1984) 1.07
Bacteriostatic effect of serum: role of antibody to lipopolysaccharide. Infect Immun (1980) 1.07
Genetic transfer of the stable L form state to intact bacterial cells. Nature (1973) 1.07
Intracellular location of the autolytic N-acetylmuramyl-L-alanine amidase in Bacillus subtilis 168 and in an autolysis-deficient mutant by immunoelectron microscopy. J Bacteriol (1991) 1.07
Wall and membrane growth in bacilli and their mutants. Ann Microbiol (Paris) (1974) 1.05
Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol (1981) 1.04
A qualitative comparison of paper flowsheets vs a computer-based clinical information system. Chest (1991) 1.04
Production of enterochelin by Escherichia coli 0111. Biochim Biophys Acta (1977) 1.04
Double mutants of Bacillus subtilis growing as helices. J Bacteriol (1978) 1.04
Influence of iron on infection. Am J Surg (1986) 1.03
Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose. Biochem Pharmacol (1972) 1.02
Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. Diabetologia (1982) 1.00
Selective extraction of polymers from cell walls of gram-positive bacteria. Biochem J (1973) 1.00
A maize pectin methylesterase-like gene, ZmC5, specifically expressed in pollen. Plant Mol Biol (1998) 0.99
Antibacterial effect of the scandium and indium complexes of enterochelin on Escherichia coli. J Gen Microbiol (1982) 0.98
Observations on salicyl hydroxamic acid, an experimental trypanocide. Experientia (1981) 0.98
Autolysins and shape change in rodA mutants of Bacillus subtilis. J Bacteriol (1978) 0.97
Morphological and cell wall alterations in thermosensitive DNA mutants of Bacillus subtilis. Ann Inst Pasteur Microbiol (1985) 0.95
Transfers from emergency room to burn center: errors in burn size estimate. J Trauma (1987) 0.94
Decreased systemic clearance of caffeine due to cimetidine. Br J Clin Pharmacol (1981) 0.93
Clinical evaluation of a computer-based patient monitoring and data management system. Heart Lung (1991) 0.93
Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release. Br J Clin Pharmacol (1985) 0.92
Iron and infection: new developments and their implications. J Trauma (1996) 0.91
Malabsorption of prednisolone from enteric-coated tablets after ileostomy. Br Med J (1980) 0.91
Iron, plasmids and infection. Nature (1980) 0.91
Effect of cimetidine on oral absorption of ampicillin and cotrimoxazole. J Antimicrob Chemother (1980) 0.91
ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol (1987) 0.91
Effect of iron compounds on antibacterial function of human polymorphs and plasma. Infect Immun (1986) 0.91
Pharmacokinetic observations on dapsone in dermatitis herpetiformis. Br J Dermatol (1983) 0.90
Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism. Br J Clin Pharmacol (1990) 0.89
Temperature-sensitive nature of the rodB maturation in Bacillus subtilis. J Bacteriol (1978) 0.89
Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation. Br J Clin Pharmacol (1981) 0.89
Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr (1986) 0.89
Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations. J Pharmacol Methods (1981) 0.88
The Arabidopsis CDC25 induces a short cell length when overexpressed in fission yeast: evidence for cell cycle function. New Phytol (2005) 0.88
Antibacterial effect of scandium and indium complexes of enterochelin on Klebsiella pneumoniae. Antimicrob Agents Chemother (1980) 0.88
Predictive value of historical and physical characteristics for the diagnosis of child abuse. South Med J (1991) 0.88
Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects. Br J Clin Pharmacol (1987) 0.87